SPR-16236-24825
3 vaccinations
4 coded responses
29 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 221 / VA
- Registered
- 2021-07-10
- Relationship
- Self
- Race
- Native Hawaiian or other Pacific Islander
- Ethnicity
- Hispanic or Latino
Registered dependents
EET-18042-18360
Adult relative or friend · Male · 2021-07-10
Timeline
-
2021-06-18
Dose 1 — Pfizer-BioNTech
-
2021-07-09
Dose 2 — Pfizer-BioNTech
-
2021-07-10
Registered in v-safe
- 2021-07-10
- 2021-07-11
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-15
- 2021-07-16
- 2021-07-30
- 2021-08-08
- 2021-08-14
- 2021-08-20
- 2021-10-09
- 2022-01-07
-
2022-01-11
Dose 3 — Pfizer-BioNTech
- 2022-01-11
-
2022-01-12
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-01-14
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Fair · Site: PainFree text: Lightheaded/dizzyMedDRA releases: 2024-11 · check-in free text available
-
2022-01-15
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: GoodFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
- 2022-01-16
- 2022-01-17
- 2022-01-18
- 2022-01-25
- 2022-02-01
- 2022-02-08
- 2022-02-15
- 2022-02-22
-
2022-04-12
Survey response — 3 months, dose 3MedDRA: Aphonia, Ear congestion, Paranasal sinus hypersecretion, Viral upper respiratory tract infection — Feeling: Good · Be unable to work or attend schoolFree text: Upper respiratory virus (sinus drainage, stuffy ears, and lost voice). It lasted about a week.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-14
Survey response — 6 months, dose 3MedDRA: Influenza like illness, Pain, Pyrexia, Upper-airway cough syndrome — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: flu-like illness starting 24 June. Days 1-3, high fever and body aches. Gradually improved each day. By day 7, only remaining symptom was an annoying post nasal discharge that lasted more than 2 weeks. Husband had exact same path 2 days laterMedDRA releases: 2024-11 · check-in free text available
- 2023-01-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-18 | Pfizer-BioNTech | No |
| 2 | 2021-07-09 | Pfizer-BioNTech | No |
| 3 | 2022-01-11 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Lightheaded/dizzy
Systemic reaction (other): Dizziness
Release 11 — 3 months, dose 3
Symptoms: Upper respiratory virus (sinus drainage, stuffy ears, and lost voice). It lasted about a week.
Release 12 — 6 months, dose 3
Symptoms: flu-like illness starting 24 June. Days 1-3, high fever and body aches. Gradually improved each day. By day 7, only remaining symptom was an annoying post nasal discharge that lasted more than 2 weeks. Husband had exact same path 2 days later cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Aphonia | · | · | ✓ |
| SD | Ear congestion | · | · | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SD | Viral upper respiratory tract infection | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release